Autoimmune Disease Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2027
Autoimmune
Disease Treatment Market Research Information: By Disease Type (Localized,
Systemic), Diagnosis (Elisa, Dot Blot, Agglutination, Others), Therapeutic
Products (Drugs, Monitoring Equipment), Distribution Channel – Global Forecast
Till 2027
Autoimmune Disease Treatment Market Highlights
An autoimmune disorder occurs
when the body’s immune system is unable to differentiate between own cells and
foreign cells, which causes the body to mistakenly attack normal cells. The
most common autoimmune disease symptoms include abdominal pain, recurring
fever, swollen glands, fatigue, and joint pain, swelling, and skin problems.
On the regional basis, the
Americas autoimmune disease treatment market is segmented into two
major regions North America and South America. The North American region holds
a major share of the global autoimmune disease treatment market owing to the
rising prevalence of autoimmune diseases, existing well-established healthcare
system, and improving funding and reimbursement policies.
According to the Centers for
Disease Control and Prevention (CDC), the total health expenditure of the
United States, in 2015, was USD 3.2 trillion and hospital care accounted a
share of 32.3%.
North America is further
segmented into the United States and Canada. The United States holds the major
share of the market owing to the well-developed economy and rising cases of
rheumatoid arthritis. According to a study published in the Rheumatology
International journal in 2017, it is found that the prevalence of rheumatoid
arthritis in the U.S. ranged from 0.53 to 0.55%. According to the Centers for
Disease Control and Prevention (CDC), in 2017, around 22.7% of adults had
doctor-diagnosed arthritis with higher prevalence in women i.e. 23.5% than in
men i.e. 18.1%.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5586
Various other factors such as,
increasing government assistance, rising prevalence of co-existing disorders,
improving regulatory framework, increase in research and development
expenditure, rising funding and reimbursement, and increasing adoption rate may
contribute to the growth of the global connective tissue disease market.
South America is still a
developing region in terms of the infrastructure and technology.
The global autoimmune disease
treatment market is segmented on the basis of disease type, diagnosis,
therapeutic products, and distribution channels.
Some of key the players in the
global autoimmune disease treatment market are Abbott Laboratories, Amgen Inc.,
Genentech Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bio-Rad, Chugai
Pharmaceutical Co. Ltd., Danaher, Elan Corporation Plc, Eli Lilly and Company,
F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Johnson &
Johnson Inc., Merck & Co. Inc., Siemens, Squibb Company, Thermo Fisher Scientific,
and others.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment